Anchor Eyecare Annapolis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 Fax: 410-349-0079 |
Dr. Jessica Yang, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2321 Forest Dr Ste E, Annapolis, MD 21401 Phone: 410-266-3369 Fax: 410-266-9448 |
Dr. Allison C Ashbeck, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2091 West St, Annapolis, MD 21401 Phone: 410-573-2020 |
Island Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 2567 Housley Rd, Annapolis, MD 21401 Phone: 410-224-2306 Fax: 410-224-0206 |
Brilliant Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1410 Forest Dr, Suite 1, Annapolis, MD 21403 Phone: 410-295-3010 Fax: 410-295-3015 |
Dr. Ashley N. Westbrook, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 701 Pearson Point Pl, Annapolis, MD 21401 Phone: 410-279-2286 |
Dr. Emily C O'meara, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2525 Riva Rd, Suite 126, Annapolis, MD 21401 Phone: 410-268-4393 Fax: 410-268-5200 |
Anne Arundel Eye Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 127 Lubrano Dr, Suite 301, Annapolis, MD 21401 Phone: 410-224-2010 Fax: 410-224-3044 |
Sterling Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2495 Annapolis Mall, Annapolis, MD 21401 Phone: 410-916-3261 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2321e Forest Dr, Annapolis, MD 21401 Phone: 410-266-3369 |
Dr. Carrie Nicole Hubbell, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 509 S Cherry Grove Ave, Spectacular Eye Care, Suite C, Annapolis, MD 21401 Phone: 410-268-4393 Fax: 410-268-5200 |
Dr. Vincente Mario Simoncini, OD Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 820 Bestgate Rd, Suite 1c, Annapolis, MD 21401 Phone: 410-266-0001 |
Dr. Jaclyn Elizabeth Coyner, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1505 Annapolis Mall, Annapolis, MD 21401 Phone: 410-573-2095 |
Dr. Miguel De Falco, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 169 Jennifer Rd Ste D, Annapolis, MD 21401 Phone: 410-224-0021 Fax: 410-224-2098 |
Shields Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 |
Anchor Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 |
Miran Kim, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1505 Annapolis Mall, Annapolis, MD 21401 Phone: 410-573-2095 |
Spectacular Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 509 S. Cherry Grove Ave, Suite C, Annapolis, MD 21401 Phone: 410-268-4393 |
Dr. George B. Shields, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1905 Towne Centre Blvd, Annapolis, MD 21401 Phone: 410-268-8200 Fax: 410-266-3996 |
Choice Vision Center Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 975 Bay Ridge Rd, Annapolis, MD 21403 Phone: 240-547-1432 Fax: 443-458-0904 |
News Archive
Researchers at UT Southwestern Medical Center have identified a signaling pathway in the brain that's sufficient to induce cellular leptin resistance, a problem that decreases the body's ability to "hear" that it is full and should stop eating.
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced that its VasoNova Inc. subsidiary has been issued CE certification from its notified body, the British Standards Institution (BSI), to market the company's Arrow VPS system to the European Union.
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S.
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
New research out of the University of Cincinnati reveals a relatively rare look into the success of substance abuse treatment programs for African-Americans. Researchers report that self-motivation could be an important consideration into deciding on the most effective treatment strategy.
› Verified 1 days ago